Healthcare | March 22, 2022
M2 milk platform to develop cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
New facility is part of Aptar Pharma’s global expansion program
Subscribe To Our Newsletter & Stay Updated
